中间型地中海贫血患者的多参数心脏磁共振:E-MIOT网络的新发现
本研究在254例β中间型地中海贫血患者中系统评估了心肌铁过载、心功能和替代性心肌纤维化。定期输血患者心脏重构较轻但心肌铁过载风险增加,替代性心肌纤维化常见且与心脏并发症相关。
要点
- 定期输血患者整体心脏T2*值更低,提示铁过载风险增加。
- 替代性心肌纤维化在40.6%接受对比剂的患者中占26.2%,与心脏并发症相关。
- 年龄和替代性心肌纤维化是心脏并发症的显著风险标志。
核心结论
- 在中间型地中海贫血中,定期输血与较轻的心脏重构相关但增加心肌铁过载风险;替代性心肌纤维化是常见发现并与心脏并发症相关。
研究设计与样本
- 研究纳入254例β中间型地中海贫血患者(43.14 ± 13.69岁,138例女性),连续入组E-MIOT项目;采用T2*技术定量心肌铁过载, cine图像评估双心室功能和心房面积, late gadolinium enhancement技术检测宏观心肌纤维化。
关键影像表现/征象
- 定期输血患者整体心脏T2*值、双心室舒张末期容积指数、左心室质量指数和心脏指数均显著低于从未/偶尔输血患者。
- 定期输血患者中,年龄和血清铁蛋白水平是整体心脏T2*值的最强预测因素。
- 心脏T2*值与双心室功能无关,且不受输血状态影响。
- 接受对比剂的103例患者中,27例(26.2%)存在替代性心肌纤维化。
- 有无替代性心肌纤维化患者间的年龄、性别分布、心脏铁和双心室功能参数相当。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: In a relatively large cohort of thalassemia intermedia (TI) patients, we systematically investigated myocardial iron overload (MIO), function, and replacement fibrosis using cardiac magnetic resonance (CMR), we assessed the clinical determinants of global heart T2* values, and we explored the association between multiparametric CMR findings and cardiac complications.
MATERIALS AND METHODS: We considered 254 beta-TI patients (43.14 ± 13.69 years, 138 females) consecutively enrolled in the Extension-Myocardial Iron Overload in Thalassemia project. MIO was quantified by T2* technique and biventricular function and atrial areas by cine images. Macroscopic myocardial fibrosis was detected by late gadolinium enhancement technique.
RESULTS: Compared to never/sporadically transfused patients, regularly transfused (RT)-TI patients exhibited significantly lower global heart T2* values, biventricular end-diastolic volume indexes, left ventricular mass index, and cardiac index. In RT-TI patients, age and serum ferritin levels were the strongest predictors of global heart T2* values. Independently from the transfusional state, cardiac T2* values were not associated with biventricular function. Of the 103 (40.6%) patients in whom the contrast medium was administrated, 27 (26.2%) had replacement myocardial fibrosis. Age, sex distribution, cardiac iron, and biventricular function parameters were comparable between patients without and without replacement myocardial fibrosis. Twenty-five (9.8%) patients had a history of cardiac complications (heart failure and arrhythmias). Increased age and replacement myocardial fibrosis emerged as significant risk markers for cardiac complications.
CONCLUSIONS: In TI, regular transfusions are associated with less pronounced cardiac remodeling but increase the risk of MIO. Replacement myocardial fibrosis is a frequent finding associated with cardiac complications.
引用
- Meloni A, Pistoia L, Ricchi P, et al. Multiparametric cardiac magnetic resonance in patients with thalassemia intermedia: new insights from the E-MIOT network. Radiol Med. 2024. PMID: 38683500. doi:10.1007/s11547-024-01821-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。